Why the study?
Is obstructive sleep apnea independently associated with an HFpEF-like phenotype in patients with revascularized coronary artery disease?
Population
435 patients with revascularized coronary artery disease and preserved left ventricular ejection fraction…
Design
Cohort
Key result
Obstructive sleep apnea severity (AHI) was associated with an HFpEF-like phenotype in CAD patients only when excluding BMI from the model (OR 1.019; 95% CI 1.005-1.033).
Authors
Loading...
OSA screening may flag HFpEF risk in CAD; leaves open independent OSA effects and CPAP benefit.
Cohort (n=435)
Is obstructive sleep apnea independently associated with an HFpEF-like phenotype in patients with revascularized coronary artery disease?
Odds Ratio: 1.019 (95% CI 1.005–1.033)
An HFpEF-like phenotype is highly prevalent (69.9%) in patients with revascularized CAD and is primarily driven by aging and obesity, with the impact of OSA severity being dependent on adiposity.
Thunström et al. (2026) conducted a cohort in Coronary artery disease and obstructive sleep apnea (n=435). Obstructive sleep apnea (OSA) severity (AHI) was evaluated on HFpEF-like phenotype (OR 1.019, 95% CI 1.005-1.033). Obstructive sleep apnea severity (AHI) was associated with an HFpEF-like phenotype in CAD patients only when excluding BMI from the model (OR 1.019; 95% CI 1.005-1.033).